Updated immunisation reference page: Tetanus

We have recently updated our tetanus reference page.

Tetanus is caused when exotoxins from the bacteria Clostridium Tetani enter the bloodstream and act on the central nervous system. Symptoms include muscle rigidity and painful spasms.

The new reference page includes new details on tetanus epidemiology, and detailed guidance on tetanus vaccination and the appropriate tetanus-prevention management of tetanus-prone wounds.

MVEC: Tetanus

Updated immunisation reference page: Pertussis

We have recently updated our pertussis reference page.

Pertussis (commonly known as whooping cough) is a highly contagious respiratory disease. Pertussis is usually more serious in infants under 6 months, but it can affect people of any age.

The updated page includes new details on pertussis epidemiology and more information about transmission. We have also published detailed guidance and recommendations for primary course and booster vaccinations across age groups.



We have recently updated our zoster (also known as shingles) reference page.

Zoster is the reactivation of the varicella zoster virus (VZV) in people who have previously had varicella (chickenpox) infection. Zoster presents with a painful blistering rash. The most common side effect is post-herpetic neuralgia.

The updated page includes new details on eligibility for the upcoming National Immunisation Program (NIP) funding for Shingrix, commencing on 1 November 2023. The page also features commonly asked questions on zoster and Shingrix.


Updated immunisation reference page: Varicella

We have recently updated our varicella reference page.

Varicella (chickenpox) is a highly contagious disease caused by infection with the varicella–zoster virus (VZV).

The updated reference page includes more details on varicella symptoms and transmission, a new section on epidemiology and more comprehensive advice on vaccination (including information on side effects, precautions and contraindications).

MVEC: Varicella

Updated immunisation reference page: MTHFR gene

We have recently updated our reference page on MTHFR gene polymorphisms.

The MTHFR gene is involved in the production of the methylenetetrahydrofolate reductase (MTHFR) enzyme, which helps the body to break down folate.

People who have MTHFR gene polymorphisms (harmless changes to the gene which are very common) can safely receive vaccines.

The updated reference page reflects up-to-date research showing MTHFR gene polymorphisms do not cause any significant health problems.


Updated immunisation reference page: Yellow fever

We have recently updated our Yellow fever reference page.

Yellow fever is an acute viral haemorrhagic disease which can be transmitted to humans via the bites of mosquitos infected with yellow fever virus (YFV). Vaccination against yellow fever is a requirement to travel to and from certain countries.

The updated reference page includes information on yellow fever epidemiology, transmission and prevention.

Updated – MVEC: Yellow fever


呼吸道合胞病毒(RSV)是幼儿呼吸道感染的主要原因之一。目前,澳大利亚还没有注册使用的 RSV 疫苗。然而,有许多疫苗正在临床试验中开发。

MVEC 最近发布了 RSV 参考页面,其中包括有关症状、传播和预防的信息。




更新后的页面包括对 Dravet 综合征儿童和其他疫苗后癫痫发作儿童进行免疫接种的最新建议。

更新 – MVEC:癫痫和免疫接种


我们最近更新了 COVID-19 免疫参考页面以简化信息。现在,您可以在一页上找到针对成人和儿童的 COVID-19 信息和建议。


更新 – MVEC:COVID-19

有关其他 COVID-19 相关信息,请参阅:

MVEC:COVID-19 疫苗和过敏

新免疫参考页:B 型流感嗜血杆菌 (Hib)

B 型流感嗜血杆菌 (Hib) 是一种疫苗可预防的流感嗜血杆菌菌株。 即使经过治疗,3% 的发生在发达国家的 Hib 脑膜炎病例将是致命的,10-30% 的病例将有永久性神经系统并发症。

在 1992 年疫苗接种被纳入国家免疫计划 (NIP) 之前,Hib 是澳大利亚儿童侵袭性细菌感染的最大原因。自那以后,报告的 Hib 感染数量减少了 95%。

我们新的免疫参考页面包括有关 Hib 传播、流行病学和预防的信息。

MVEC:B 型流感嗜血杆菌 (Hib)